drugset / Trial / NCT03175731

PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors)

NCT03175731

Phase 4 Completed 106 enrolled Yanjing Gao
RandomizedParallel-groupSingle-blindTreatment

Summary

This study is aimed at investigating the effect of PPIs on gastroesophageal varices in liver cirrhosis. Half of participants will receive PPI, while the other half will receive a placebo.

Timeline

Start
2017-05-01
Primary completion
2019-08-30
Completion
2019-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Pantoprazole Other / unclassified 40 mg Intravenous